{"id":"https://openalex.org/W646749392","doi":null,"title":"Simultaneous modeling of endogenous G\u2011CSF and neutrophil dynamics following chemotherapy in breast cancer patients","display_name":"Simultaneous modeling of endogenous G\u2011CSF and neutrophil dynamics following chemotherapy in breast cancer patients","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W646749392","mag":"646749392"},"language":"en","primary_location":{"id":"mag:646749392","doi":null,"is_oa":false,"landing_page_url":"https://www.researchgate.net/profile/Henrik_Lindman/publication/266462882_Simultaneous_modeling_of_endogenous_GCSF_and_neutrophil_dynamics_following_chemotherapy_in_breast_cancer_patients/links/5523870d0cf29dcabb0f01f3.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091201149","display_name":"Angelica Linnea Quartino","orcid":"https://orcid.org/0000-0003-0184-4670","observed_orcids":["https://orcid.org/0000-0003-0184-4670"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Angelica Quartino","raw_affiliation_strings":["Uppsala University ,"],"raw_orcid":"https://orcid.org/0000-0003-0184-4670","affiliations":[{"raw_affiliation_string":"Uppsala University ,","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070310610","display_name":"Mats O. Karlsson","orcid":"https://orcid.org/0000-0003-1258-8297","observed_orcids":["https://orcid.org/0000-0003-1258-8297"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mats O. Karlsson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1258-8297","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065433718","display_name":"Henrik Lindman","orcid":"https://orcid.org/0000-0002-5871-268X","observed_orcids":["https://orcid.org/0000-0002-5871-268X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Henrik Lindman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5074482150","display_name":"Lena E. Friberg","orcid":"https://orcid.org/0000-0002-2979-679X","observed_orcids":["https://orcid.org/0000-0002-2979-679X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lena E. Friberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.011800000444054604,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12919","display_name":"Blood disorders and treatments","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8180000185966492},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.8360000252723694},{"id":"https://openalex.org/keywords/chemotherapy-induced-myelosuppression","display_name":"chemotherapy-induced myelosuppression","score":0.8349999785423279},{"id":"https://openalex.org/keywords/leukocyte-dynamics","display_name":"leukocyte dynamics","score":0.578000009059906},{"id":"https://openalex.org/keywords/neutrophil-count","display_name":"neutrophil count","score":0.7239999771118164},{"id":"https://openalex.org/keywords/liver-function-impairment","display_name":"liver function impairment","score":0.7170000076293945},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9139999747276306},{"id":"https://openalex.org/keywords/daunorubicin","display_name":"daunorubicin","score":0.996999979019165},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.996999979019165},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7620000243186951},{"id":"https://openalex.org/keywords/in-vitro-drug-sensitivity","display_name":"in vitro drug sensitivity","score":0.9599999785423279},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.7239999771118164},{"id":"https://openalex.org/keywords/dose-selection","display_name":"dose selection","score":0.5450000166893005},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.5460000038146973}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.8935776352882385},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.845220685005188},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7550418376922607},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6279237866401672},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5734285712242126},{"id":"https://openalex.org/C2777767877","wikidata":"https://www.wikidata.org/wiki/Q419327","display_name":"Granulocyte colony-stimulating factor","level":3,"score":0.5553733110427856},{"id":"https://openalex.org/C74133956","wikidata":"https://www.wikidata.org/wiki/Q4669824","display_name":"Absolute neutrophil count","level":4,"score":0.5288950800895691},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.49321430921554565},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.4876483678817749},{"id":"https://openalex.org/C2777983669","wikidata":"https://www.wikidata.org/wiki/Q223143","display_name":"Granulocyte","level":2,"score":0.48477429151535034},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4722420871257782},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4093019664287567},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3905019462108612},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3454131484031677}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:646749392","doi":null,"is_oa":false,"landing_page_url":"https://www.researchgate.net/profile/Henrik_Lindman/publication/266462882_Simultaneous_modeling_of_endogenous_GCSF_and_neutrophil_dynamics_following_chemotherapy_in_breast_cancer_patients/links/5523870d0cf29dcabb0f01f3.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W720469","https://openalex.org/W109252363","https://openalex.org/W219670142","https://openalex.org/W1517281160","https://openalex.org/W1544977897","https://openalex.org/W1550111394","https://openalex.org/W1790036423","https://openalex.org/W1811706705","https://openalex.org/W1828514487","https://openalex.org/W1850413414","https://openalex.org/W1978464652","https://openalex.org/W1979617441","https://openalex.org/W1981127449","https://openalex.org/W1981373522","https://openalex.org/W1981532739","https://openalex.org/W1988722349","https://openalex.org/W1989468827","https://openalex.org/W1993109650","https://openalex.org/W1998279515","https://openalex.org/W2000054190","https://openalex.org/W2012899038","https://openalex.org/W2018739014","https://openalex.org/W2026736608","https://openalex.org/W2032414164","https://openalex.org/W2037504528","https://openalex.org/W2048302836","https://openalex.org/W2050061928","https://openalex.org/W2050088084","https://openalex.org/W2053500878","https://openalex.org/W2061551675","https://openalex.org/W2066801806","https://openalex.org/W2081194776","https://openalex.org/W2082535104","https://openalex.org/W2089827209","https://openalex.org/W2097139146","https://openalex.org/W2128664606","https://openalex.org/W2152807596","https://openalex.org/W2163491269","https://openalex.org/W2167689077","https://openalex.org/W2168860536","https://openalex.org/W2207129583","https://openalex.org/W2343519676","https://openalex.org/W2617679952"],"related_works":["https://openalex.org/W11584463","https://openalex.org/W611177787","https://openalex.org/W2038639830","https://openalex.org/W1239088256","https://openalex.org/W2097139146","https://openalex.org/W2067242226","https://openalex.org/W1975228131","https://openalex.org/W3046267018","https://openalex.org/W2039689365","https://openalex.org/W3180369481"],"abstract_inverted_index":{"Chemotherapy":[0],"plays":[1],"an":[2,377],"important":[3],"role":[4],"in":[5,20,183,232,246,258,268,294,311,320,329,346,352,368,376],"the":[6,48,81,87,111,178,215,219,310,353,400],"treatment":[7,55,79,267,316,327],"of":[8,16,80,86,89,98,104,130,141,154,176,196,218,278,309,340,355,390],"cancer.":[9],"However,":[10],"these":[11,142],"drugs":[12,362],"also":[13,212,386],"cause":[14],"death":[15],"non-malignant":[17],"cells,":[18],"resulting":[19],"severe":[21],"side-effects.":[22],"In":[23,39],"addition,":[24],"drug":[25,34,289,313,322,369],"resistance":[26,290],"may":[27,334,349,385],"exist.":[28],"Predictive":[29],"tools":[30],"for":[31,47,54,66,230,300,326,338,358,399],"dose":[32,74,371],"and":[33,53,69,76,100,115,193,199,236,251,284,291,315,333,360,370,382,392],"selection":[35,372],"are":[36,118],"therefore":[37,335],"warranted.":[38],"this":[40,269,330,347],"thesis":[41,348],"predictive":[42,325],"pharmacometric":[43,344,401],"models":[44,345,381],"were":[45,224],"developed":[46,137,210,343],"main":[49,151],"dose-limiting":[50],"side-effect,":[51],"neutropenia,":[52,172],"response":[56,317],"following":[57,185,201],"chemotherapy.":[58,186],"Neutropenia":[59],"is":[60,125,156,165,174,286],"associated":[61,287],"with":[62,234,260,282,288],"a":[63,204,227,243,252],"high":[64,292],"risk":[65],"life-threatening":[67],"infections":[68],"leads":[70],"frequently":[71],"to":[72,108,145,170,208,366,373],"reduced":[73,253],"delivery":[75],"thereby":[77,264],"suboptimal":[78],"tumor.":[82],"A":[83,134,187],"better":[84],"characterization":[85],"dynamics":[88],"docetaxel":[90,231,266],"induced":[91],"neutropenia":[92,131],"was":[93,106,136,190,242,256,297,324],"obtained":[94],"by":[95,302],"simultaneous":[96,194],"analysis":[97,140,195,389],"neutrophils":[99,105,155,200],"leukocytes.":[101],"The":[102,150,240,342,380],"fraction":[103],"shown":[107],"change":[109],"over":[110],"time-course,":[112],"hence":[113],"leukocytes":[114],"neutrophil":[116,123],"counts":[117],"not":[119],"interchangeable":[120],"biomarkers.":[121],"Sometimes":[122],"count":[124],"reported":[126],"as":[127,167,363,365],"categorical":[128],"severity":[129],"(Grade":[132],"0-4).":[133],"method":[135],"that":[138,211,319],"allowed":[139],"data":[143,391],"closer":[144],"its":[146],"true":[147],"continuous":[148],"nature.":[149],"regulatory":[152],"hormone":[153],"granulocyte":[157],"colony":[158],"stimulating":[159],"factor":[160],"(G-CSF).":[161],"Although":[162],"recombinant":[163],"G-CSF":[164,180,198],"used":[166,337],"supportive":[168],"therapy":[169,375],"prevent":[171],"little":[173],"known":[175],"how":[177],"endogenous":[179,197],"concentrations":[181],"vary":[182],"patients":[184,233,259],"prospective":[188],"study":[189],"carried":[191],"out":[192],"chemotherapy":[202],"enabled":[203],"more":[205],"mechanistic":[206],"model":[207,229,241,308],"be":[209,336,350,397],"could":[213,396],"verify":[214],"self-regulatory":[216],"properties":[217],"physiological":[220],"system.":[221],"Patient":[222],"characteristics":[223],"investigated":[225],"using":[226],"pharmacokinetic-myelosuppression":[228],"normal":[235],"impaired":[237],"liver":[238,262],"function.":[239],"useful":[244,351,398],"tool":[245],"evaluating":[247],"different":[248],"dosing":[249,254],"strategies":[250],"scheme":[255],"suggested":[257],"poor":[261],"function,":[263],"enabling":[265],"patient":[270,331],"population":[271,332],"which":[272,296,395],"has":[273],"previously":[274],"been":[275],"excluded.":[276],"Treatment":[277],"acute":[279],"myeloid":[280],"leukemia":[281],"daunorubicin":[283,301],"cytarabine":[285],"variability":[293],"pharmacokinetics,":[295],"partly":[298],"explained":[299],"peripheral":[303],"leukocyte":[304],"count.":[305],"An":[306],"integrated":[307],"vitro":[312,321],"sensitivity":[314,323],"showed":[318],"outcome":[328],"choice":[339],"drug.":[341],"optimization":[354],"treatments":[356],"schedules":[357],"existing":[359],"new":[361],"well":[364],"assist":[367],"improve":[374],"individual":[378],"patient.":[379],"methods":[383],"presented":[384],"facilitate":[387],"pooled":[388],"demonstrate":[393],"principles":[394],"community.":[402]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}